VERX
Earnings company data as of 11:02 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.15 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by VERX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $6.5M bought by 4 insiders
- $82K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
David DeStefano DirectorSale$82K 6,460 shares at $12.75 3.2% of stakeTraded May 28 Filed Jun 1
-
ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001 10% ownerBuy$150K 10,000 shares at $15.05 +0.8% to stakeTraded Mar 9 Filed Mar 9
-
Christopher David Young CEOBuy$731K 60,000 shares at $12.18 New stakeTraded Feb 23 Filed Feb 25
-
Eric C. Andersen DirectorBuy$516K 40,000 shares at $12.91 +36% to stakeTraded Feb 20 Filed Feb 23
-
Jeffrey Westphal InsiderBuy$5.1M 397,740 shares at $12.88 New stakeTraded Feb 13–17 Filed Feb 18
Also filed in the last 12 months, not counted as buying or selling: 15 share withholdings for taxes, 15 option exercises, and 9 stock grants.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 5.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.05 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.